The estimated Net Worth of Ricci S Whitlow is at least $24.5 million dollars as of 16 February 2024. Ms. Whitlow owns over 30,764 units of Catalent stock worth over $23,914,612 and over the last 5 years she sold CTLT stock worth over $606,986. In addition, she makes $0 as President - Clinical Supply Services at Catalent.
Ricci has made over 5 trades of the Catalent stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 30,764 units of CTLT stock worth $247,343 on 16 February 2024.
The largest trade she's ever made was selling 31,043 units of Catalent stock on 14 February 2024 worth over $249,896. On average, Ricci trades about 5,706 units every 103 days since 2020. As of 16 February 2024 she still owns at least 401,050 units of Catalent stock.
You can see the complete history of Ms. Whitlow stock trades at the bottom of the page.
Ricci Whitlow has been appointed as President - Clinical Supply Services of the Company effective 3/2020. Ms. Whitlow's position will continue to report to Alessandro Maselli , the company's President and Chief Operating Officer. As President of the business unit, she will have global responsibility for all aspects of Catalent's clinical supply business, which, in fiscal 2019, generated $321.4 million in revenue and $84.4 million in Segment EBITDA. Catalent's clinical supply network includes nine cGMP-certified clinical packaging, storage, and distribution facilities across North America , Europe and Asia , and more than 50 strategically located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. Ms. Whitlow has over 25 years' experience in commercial, operations, and general management roles within the pharmaceutical biologics and medical device industry, and she rejoins Catalent after two-and-a-half years, having previously held the position of VP Operations, overseeing nine manufacturing facilities across North and South America . Her most recent position was with OptiNose, where she served as Senior Vice President of Technical and Corporate Operations, and she has also worked for LifeCell and Johnson & Johnson during her career. Ms. Whitlow holds a master's degree in business administration from the TRIUM program of NYU Stern School of Business, London School of Economics and HEC Paris; as well as a Bachelor of Science in Industrial Engineering from Texas A&M University . She is also a certified Six Sigma green belt.
Ricci's mailing address filed with the SEC is 1775 WEST OAK COMMONS COURT NE, , MARIETTA, GA, 30062.
Over the last 10 years, insiders at Catalent have traded over $2,686,980,380 worth of Catalent stock and bought 123,000 units worth $5,376,345 . The most active insiders traders include Management Associates V L.L..., Peter Zippelius et Frank A Damelio. On average, Catalent executives and independent directors trade stock every 17 days with the average trade being worth of $22,866,018. The most recent stock trade was executed by Ricky Hopson on 2 August 2024, trading 662 units of CTLT stock currently worth $39,429.
catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p
Catalent executives and other stock owners filed with the SEC include: